Outcomes Associated With Andexanet Use in Patients With Factor Xa Inhibitor-Associated Intracranial Hemorrhage: A One-Year Single-Center Analysis

被引：0
|
作者：
Concha, M. [1 ]
Shomo, E. [1 ]
Busey, K., V [1 ]
Case, D. [1 ]
Brockhurst, A. [1 ]
Giovino, A. [1 ]
机构：
[1] Sarasota Mem Hosp, Sarasota, FL USA
来源：
ANNALS OF EMERGENCY MEDICINE | 2019年 / 74卷 / 04期
关键词：
D O I：
10.1016/j.annemergmed.2019.08.369
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
201
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [31] Single-center experience with rituximab in the treatment of inhibitor-associated hemostatic disorders
    Hammond, D.
    Saidenberg, E.
    Tinmouth, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 762 - 762
  • [32] Economic Evaluation of Andexanet Versus Prothrombin Complex Concentrate for Reversal of Factor Xa-Associated Intracranial Hemorrhage
    Micieli, Andrew
    Demchuk, Andrew M.
    Wijeysundera, Harindra C.
    STROKE, 2021, 52 (04) : 1390 - 1397
  • [33] Activated Prothrombin Complex Concentrates for the Treatment of Factor Xa Inhibitor-Associated Spontaneous Intracerebral Hemorrhage
    Rowe, A. Shaun
    Hamilton, Leslie A.
    Barber, Jacob A.
    Dinh, Theresa
    Randolph, Allison
    Christianson, Thomas
    JOURNAL OF PHARMACY TECHNOLOGY, 2023, 39 (06) : 286 - 290
  • [34] Treatment of Factor-Xa Inhibitor-associated Bleeding with Andexanet Alfa or 4 Factor PCC: A Multicenter Feasibility Retrospective Study
    Singer, Adam J.
    Concha, Mauricio
    Williams, James
    Brown, Caitlin S.
    Fernandes, Rafael
    Thode, Henry C., Jr.
    Kirchman, Marylin
    Rabinstein, Alejandro A.
    WESTERN JOURNAL OF EMERGENCY MEDICINE, 2023, 24 (05) : 939 - 949
  • [35] Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor-associated bleeding: Case series
    Liu, JiTong
    Elsamadisi, Pansy
    Philips, Eli
    Bauer, Kenneth A.
    Eche, Ifeoma M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (16) : 1323 - 1329
  • [36] One year clinical outcomes associated with the use of a Zotarolimus eluting stent: A Single-Center Canadian Experience
    Drzymala, Luke
    Ha, Andrew
    So, Derek
    Glover, Chris
    CIRCULATION, 2007, 116 (16) : 467 - 467
  • [37] One year clinical outcomes associated with the use of a Zotarolimus eluting stent: A single-center Canadian experience
    Drzymala, L.
    Ha, A.
    So, D.
    Glover, C.
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 61C - 61C
  • [38] Efficacy and Safety of Andexanet Alfa Versus Four Factor Prothrombin Complex Concentrate for Emergent Reversal of Factor Xa Inhibitor Associated Intracranial Hemorrhage: A Systematic Review and Meta-Analysis
    Sarhan, Khalid
    Mohamed, Rashad G.
    Elmahdi, Reem Reda
    Mohsen, Youstina
    Elsayed, Asmaa
    Zayed, Dania Mosaad
    Elkholi, Menna A.
    Gabr, Nagat
    El-Bialy, Enjy M.
    Serag, Ibrahim
    NEUROCRITICAL CARE, 2025, 42 (02) : 701 - 714
  • [39] Efficacy and Safety of Andexanet Alpha Versus Four Factor Prothrombin Complex Concentrate for Emergent Reversal of Factor Xa Inhibitor Associated Intracranial Hemorrhage: A Systematic Review and Meta-Analysis
    Sarhan, Khalid
    Mohamed, Rashad G.
    Elmahdi, Reem Reda
    Mohsen, Youstina
    Elsayed, Asmaa
    Zayed, Dania Mosaad
    Elkholi, Menna A.
    Gabr, Nagat
    El-Bialy, Enjy M.
    Serag, Ibrahim
    NEUROSURGERY, 2025, 71 : 208 - 208
  • [40] Efficacy and safety of Andexanet Alfa for factor XA inhibitors use associated intracranial bleeding: A systematic review and meta-analysis
    Shrestha, Dhan
    Budhathoki, Pravash
    Adhikari, Ayush
    Shrestha, Sudat
    Khati, Nirajan
    Joshi, Tilak
    Shrestha, Anuj
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
12345